Chemistry: molecular biology and microbiology – Maintaining blood or sperm in a physiologically active state...
Patent
1995-01-13
1997-04-08
Beisner, William H.
Chemistry: molecular biology and microbiology
Maintaining blood or sperm in a physiologically active state...
4352831, 4353081, 530380, 530412, A01N 102
Patent
active
056186630
DESCRIPTION:
BRIEF SUMMARY
FIELD OF THE INVENTION
The present invention relates to a process for the preparation of platelet factors (contents of thrombocytic granules) and to a device which makes possible the activation of thrombocytes, of human or animal origin, stored on or in a polymeric framework for the purpose of obtaining, in a short time and without risk of external contamination, soluble molecules having a biological activity.
BACKGROUND
The solution of platelet factors released by the activated thrombocytes (also known as "platelets") is often denoted by the expression "activated-thrombocyte supernatant".
Activated-thrombocyte supernatants are currently used as starting materials for the purification of biological molecules, such as, for example: platelet-derived growth factor, transforming growth factor-.beta., basic fibroblast growth factor, platelet factor 4, platelet-derived endothelial growth factor, heparin-binding epidermal growth factor, insulin-like growth factor 1, connective tissue activating peptide III, .beta.-thromboglobulin, epidermal growth factor, plasminogen, Von Willsbrand factor, fibrinogen, serotonin, histamine, adenosine di- and triphosphate, fibronectin, vitronectin, factor XIII, proteolytic or glycolytic enzymes, or the metabolites of arachidonic acid (see the review, Inflammation and Repair, H. L. Wong & S. M. Wahl, in "Peptide Growth Factors and their Receptors", p. 510, edited by Sporn & Roberts, Springer-Verlag, Berlin; Platelets and Response to Injury, R. A. Terkeltaub & M. H. Ginsberg, in "The Molecular and Cellular Biology of Wound Repair", p. 38, edited by Clark & Henson, Plenum Press, New York).
Certain purification methods are known and were able to form the subject of patent filings. Mention may especially be made of: European Patent No. 89100148.9 relating to the purification of transforming growth factor-.beta. and U.S. Pat. No. 4,479,896 relating to the purification of platelet-derived growth factor.
Activated-thrombocyte supernatants (or a fraction of these supernatants) can be used in therapy, for example for their healing activity (D. Knighton et al., Ann. Surg. (1982) 196, 379-388; D. M. Carter et al., in: Growth Factors and Other Aspects in Wound Healing, p. 303-317, edited by Barbul, Pines, Cadwell and Hunt, Alan R. Liss Inc., New York, 1988; U.S. Pat. No. 4,760,131; Patent WO 88/03409; Patent WO 86/03122; Patent WO 89/05656), or in cosmetology, for example for their beneficial effect in controlling alopecia (Patent WO 90/07931).
Platelet factors contained in activated-thrombocyte supernatants can be used especially in the treatment of ulcers.
The methods described to date for the preparation of thrombocytic supernatants are lengthy (minimum duration of approximately 1 hour 30 minutes), tedious (because they require transfers from tube to tube, getting the centrifuging balanced, pipettings) and virtually impossible to automate and they present risks of contamination of the product by its environment (transfers of liquids in open-necked vessels) or of the technician by the product being handled, which is potentially infected by transmittable germs.
In fact, these preparation methods begin with the isolation of the thrombocytes from the blood by successive centrifugings. The thrombocytes are then washed by centrifuging to remove the plasma (Isolation of Platelets, in: Methods in Enzymology, Section I, pp. 3-27, Vol. 169, edited by Hawiger, Academic Press, London, 1989; Patent WO 86/03122, U.S. Pat. No. 4,760,131). The purified thrombocytes are then suspended in the presence of an activator. Many activators are known (Platelets and Response to Injury, R. A. Terkeltaub & M. H. Ginsberg, in "The Molecular and Cellular Biology of Wound Repair", pp. 35-55, edited by Clark a Henson, Plenum Press, New York). Three types of activators are distinguished: strong activators which are capable of inducing secretion from all the granules (thrombin, collagen, calcium ionophore A23187), intermediate activators such as thromboxane A2, ADP in the presence or absence of calcium ions, or adrenali
REFERENCES:
patent: 4360435 (1982-11-01), Bellamy et al.
patent: 4410630 (1983-10-01), Zierdt
patent: 4479896 (1984-10-01), Antoniades
patent: 4618494 (1986-10-01), Angers
patent: 4705632 (1987-11-01), Yagita et al.
patent: 4731260 (1988-03-01), Balding et al.
patent: 4760131 (1988-07-01), Sundsmo et al.
patent: 4931185 (1990-06-01), Bourgeois et al.
D. R. Knighton et al., "Role of Platelets and Fibrin in the Healing Sequence", Annal of Surgery, No. 4, vol. 196, Oct. 1982, pp. 379-387.
R. A. Terkeltaub et al., "Platelets and Response to Injury", The Molecular and Cellular Biology of Wound Repair, pp. 36-55, No Date Provided.
D. M. Carter et al. "Clinical Experience With Crude Preparations of Growth Factors in Healing of Chronic Wounds in Human Subjects", Growth Factors and Other Aspects of Wound Healing: Biological and Clinical Implications, pp. 303-317 (1988).
J. N. Linden et al., "Platelet Interaction with Artificial Surfaces: in Vitro Evaluation", Methods in Enzymology, vol. 169, pp. 104-117 (1989).
J. F. Mustard et al., "Isolation of Human Platelets from Plasma by Centrifugation and Washing", Methods in Enzymology, vol. 169, pp. 3-27 (1989).
H. L. Wong et al., "Imflammation and Repair", Peptide Growth Factors and their Receptors, pp. 509-548. No Date Provided.
Beisner William H.
Delmas Olivier
Inoteb
LandOfFree
Device for producing a supernatant of activated thrombocytes, me does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Device for producing a supernatant of activated thrombocytes, me, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Device for producing a supernatant of activated thrombocytes, me will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397070